Published in Vaccine Weekly, May 8th, 2002
Described in an oral presentation at the 93rd annual meeting of the American Association for Cancer Research, the data show that in these patients, treatment with Oncophage can induce significant expansion of cancer-specific immune responses, and that the induction mechanism is the same for both cancers.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.